Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The CLEAR Trial: Ceasing aLpha-blockers Early After Resection of the Prostate
NCT07846579Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Dec 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 4 trial of tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Shanghai East Hospital. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT07846579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07846579.